MIF and neoplasm: It is suggested that the major humoral component of the immune response to FBJ sarcoma cells is evoked against antigens specified by the associated non-pathogenic leukaemia virus (MLV-FBJ) and the relationship of antigens demonstrated by MIF to those detected previously by complement fixation (CF) and tumour rejection tests is discussed.